All In MedTech

FDA Clearance Tracker · P960004-S113

FINELINE™ II Sterox and Sterox EZ pace/sense leads

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 6, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 6, 2026

Approved

Time to decision

37 days

Received Jan 28, 2026. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P960004-S113
Device name
FINELINE™ II Sterox and Sterox EZ pace/sense leads
Applicant location
St Paul, MN
Received
Jan 28, 2026
Decided
Mar 6, 2026
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P960004

Device type

Device class
Class III

Every decision under product code NVN

FDA's approval statement

As written in FDA's record.

approval for the related transfer of the downstream final packaging process from the Boston Scientific Puerto Rico Dorado site to Boston Scientific Quincy, Massachusetts facility to enable regionally co-located operations for the CRM leads.

Source documents

Other decisions for Boston Scientific

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.